Literature DB >> 3190955

Electrocardiographic prediction of coronary artery patency after thrombolytic treatment in acute myocardial infarction: use of the ST segment as a non-invasive marker.

K J Hogg1, R S Hornung, C A Howie, N Hockings, F G Dunn, W S Hillis.   

Abstract

The predictive value of the measurement of changes in ST segment elevation was assessed as a non-invasive marker of coronary artery reperfusion after thrombolytic treatment. Forty five patients with acute myocardial infarction (23 anterior, 22 inferior) of less than six hours' duration were given thrombolytic treatment by either the intravenous (n = 28) or the intracoronary route (n = 17). A proportional value for the shift in ST segment, termed the fractional change, was calculated both from 12 lead electrocardiograms and from the Holter tape for each patient. Coronary artery patency in an initial group of 22 patients (training group) was associated with a fractional change value of greater than or equal to 0.5 (100% specific, 88% sensitive by Holter analysis; 100% specific, 94% sensitive by 12 lead electrocardiogram). This rule performed well when it was applied to a test group of 17 patients (100% specific, 93% sensitive by Holter analysis; and 67% specific, 93% sensitive by 12 lead electrocardiogram). Linear discriminant analysis was then used to determine which features gave the best separation of those in whom there was reperfusion and those in whom there was not. This gave 100% specificity and 100% sensitivity when applied to the training group for either the 12 lead electrocardiogram or Holter monitoring. When it was applied to the test group, the sensitivity was maintained at 100%, but the specificity dropped to 33% irrespective of whether the basis of the test was Holter monitoring or the 12 lead electrocardiogram. These results suggest that a fractional change of >/= 0.5 calculated from a single lead showing myocardial injury is a useful non-invasive marker of reperfusion. The technique can be applied to either 12 lead electrocardiograms or Holter monitoring. The use of a more complex classification increased the sensitivity of the test at the expense of its specificity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3190955      PMCID: PMC1216573          DOI: 10.1136/hrt.60.4.275

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  15 in total

1.  Evaluation of precordial electrocardiographic mapping as a means of assessing changes in myocardial ischemic injury.

Authors:  J E Muller; P R Maroko; E Braunwald
Journal:  Circulation       Date:  1975-07       Impact factor: 29.690

2.  The western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. A 12-month follow-up report.

Authors:  J W Kennedy; J L Ritchie; K B Davis; M L Stadius; C Maynard; J K Fritz
Journal:  N Engl J Med       Date:  1985-04-25       Impact factor: 91.245

3.  Coronary thrombolysis with intravenous anisoylated plasminogen-streptokinase complex BRL 26921.

Authors:  M Been; D P de Bono; A L Muir; F E Boulton; W S Hillis; R Hornung
Journal:  Br Heart J       Date:  1985-03

4.  Early intraaortic balloon pumping for anterior myocardial infarction without shock.

Authors:  R C Leinbach; H K Gold; R W Harper; M J Buckley; W G Austen
Journal:  Circulation       Date:  1978-08       Impact factor: 29.690

5.  A randomized trial of intravenous and intracoronary streptokinase in patients with acute myocardial infarction.

Authors:  J L Anderson; H W Marshall; J C Askins; J R Lutz; S G Sorensen; R L Menlove; F G Yanowitz; A D Hagan
Journal:  Circulation       Date:  1984-10       Impact factor: 29.690

6.  Myocardial infarction and thrombolysis. Electrocardiographic short term and long term results using precordial mapping.

Authors:  R von Essen; W Schmidt; R Uebis; B Edelmann; S Effert; J Silny; G Rau
Journal:  Br Heart J       Date:  1985-07

7.  Intravenous short-term infusion of streptokinase in acute myocardial infarction.

Authors:  R Schröder; G Biamino; E R von Leitner; T Linderer; T Brüggemann; J Heitz; H F Vöhringer; K Wegscheider
Journal:  Circulation       Date:  1983-03       Impact factor: 29.690

8.  Pericarditis after acute myocardial infarction.

Authors:  U Thadani; M P Chopra; C P Aber; R W Portal
Journal:  Br Med J       Date:  1971-04-17

9.  Propranolol-induced reduction of signs of ischemic injury during acute myocardial infarction.

Authors:  H K Gold; R C Leinbach; P R Maroko
Journal:  Am J Cardiol       Date:  1976-11-23       Impact factor: 2.778

10.  Favorable effects of hyaluronidase on electrocardiographic evidence of necrosis in patients with acute myocardial infarction.

Authors:  P R Maroko; L D Hillis; J E Muller; L Tavazzi; G R Heyndrickx; M Ray; M Chiariello; A Distante; J Askenazi; J Salerno; J Carpentier; N I Reshetnaya; P Radvany; P Libby; D S Raabe; E I Chazov; P Bobba; E Braunwald
Journal:  N Engl J Med       Date:  1977-04-21       Impact factor: 91.245

View more
  27 in total

1.  ECG monitoring, biochemical Testing, and Anticoagulation Assessment.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

Review 2.  The use of the electrocardiogram to identify epicardial coronary and tissue reperfusion in acute myocardial infarction.

Authors:  M Vaturi; Y Birnbaum
Journal:  J Thromb Thrombolysis       Date:  2000-10       Impact factor: 2.300

Review 3.  ST segment changes as a surrogate end point in coronary thrombolysis.

Authors:  W S Hillis; K J Hogg
Journal:  Br Heart J       Date:  1990-08

4.  French multicenter trial of anistreplase versus heparin in acute myocardial infarction.

Authors:  H Lardoux; Y Louvard; D de Vernejoul; C Picot; M Baudet; M Hiltgen; M Houplon; J Ponsonnaille; M Richard; R Luccioni
Journal:  Cardiovasc Drugs Ther       Date:  1990-10       Impact factor: 3.727

5.  Feasibility and long term outcome of home vs hospital initiated thrombolysis.

Authors:  B McAleer; M P S Varma
Journal:  Ir J Med Sci       Date:  2006 Oct-Dec       Impact factor: 1.568

6.  Serum myoglobin and creatine kinase enzymes in acute myocardial infarction treated with Anistreplase.

Authors:  D A McCullough; P G Harrison; J M Forshall; J B Irving; R J Hillman
Journal:  J Clin Pathol       Date:  1992-05       Impact factor: 3.411

7.  Evaluation of mortality and morbidity during four years after late thrombolysis in acute myocardial infarct.

Authors:  A Liguori; F DiGregorio; C Napoli
Journal:  Heart       Date:  1996-09       Impact factor: 5.994

8.  Electrocardiographic evidence of myocardial salvage after thrombolysis in acute myocardial infarction.

Authors:  K J Hogg; K R Lees; R S Hornung; C A Howie; F G Dunn; W S Hillis
Journal:  Br Heart J       Date:  1989-06

9.  Serum Lp(a) lipoprotein concentration and outcome of thrombolytic treatment for myocardial infarction.

Authors:  A D MBewu; P N Durrington; M I Mackness; L Hunt; W H Turkie; J E Creamer
Journal:  Br Heart J       Date:  1994-04

10.  Prehospital thrombolysis in a rural community: short- and long-term survival.

Authors:  B McAleer; B Ruane; E Burke; M Cathcart; A Costello; G Dalton; J R Williams; M P Varma
Journal:  Cardiovasc Drugs Ther       Date:  1992-08       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.